实性胰腺病变中非典型与可疑诊断的细胞形态学特征及观察者间差异
该研究回顾124例实性胰腺病变的FNA/B标本(87例涂片、37例FNBs),分析非典型(ATY)与可疑(SUS)诊断的恶性风险及形态学特征,并通过7名观察者盲法复阅40例涂片和20例FNBs评估观察者间一致性。结果显示两类诊断恶性风险均高,涂片形态学区分ATY与SUS较明确,而FNBs可区分特征少且重复性更低。
要点
- 实性胰腺病变中ATY和SUS诊断均与高恶性风险相关。
- 涂片上ATY多示细胞量少,SUS多示核大小差异≥4:1。
- FNBs观察者间一致性低于涂片,且区分特征较少。
核心结论
- 实性胰腺病变的ATY和SUS诊断均具有高恶性风险。
- 涂片形态学特征有助于从ATY升级为SUS,而FNBs可区分特征少且重复性低。
- 建议继续细化针对标本类型的形态学标准并加强教育培训以减少报告差异。
研究设计与样本
- 回顾性分析2014至2024年124例实性胰腺肿块FNA/B标本,包括87例涂片和37例FNBs,原诊断为ATY或SUS。
- 排除16例涂片和3例FNBs的非腺癌恶性肿瘤,用于结局和形态学分析。
- 由4名细胞病理医师和3名细胞病理学fellows对40例涂片和20例FNBs进行盲法复阅以评估观察者间差异。
主要发现
- 恶性风险:涂片ATY为72.3%,SUS为90.0%;FNBs ATY为80.0%,SUS为100%。
- 观察者间一致性:涂片κ=0.355(fair),FNBs κ=0.218(较低),fellows比staff更常给出ATY/SUS诊断。
临床怎么用
- 对实性胰腺病变的ATY和SUS诊断应警惕高恶性风险并密切随访。
- 涂片诊断时可结合细胞量少和核大小差异≥4:1等特征辅助区分ATY与SUS。
- FNBs诊断ATY/SUS时需注意观察者间一致性较低,建议结合临床及影像学。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Atypical (ATY) and suspicious (SUS) diagnoses in fine-needle aspiration/biopsy (FNA/B) of solid pancreatic lesions remain challenging to consistently apply. The most relevant cytomorphologic features and reproducibility of these interpretations across direct smears and FNBs are not well characterized. METHODS: In total, 124 FNA/B specimens (87 smears, 37 FNBs) from solid pancreatic masses originally diagnosed as ATY or SUS were identified (from 2014 to 2024). Clinical/pathologic follow-up was reviewed, and morphologic features were systematically assessed. Interobserver variability was evaluated using blinded re-interpretation of 40 smears and 20 FNBs by four cytopathologists and three cytopathology fellows. RESULTS: Non-adenocarcinoma malignancies (16 smears and 3 FNBs) were excluded for outcomes and morphologic analysis. The risk of malignancy was high in both categories (smears: ATY, 72.3%; SUS, 90.0%; FNBs: ATY, 80.0%; SUS, 100%). ATY smears more often showed scant cellularity (87.8% vs. 59.1% of SUS smears; p = .011), whereas SUS cases more commonly demonstrated anisonucleosis ≥4:1 (54.5% vs. 20.4%; p = .010). On FNBs, background chronic pancreatitis was significantly more frequent in SUS cases (75.0% vs. 11.5%; p = .001). Interobserver agreement was fair for smears (κ = 0.355) and lower for FNBs (κ = 0.218), with fellows rendering ATY/SUS diagnoses more frequently than staff cytopathologists. CONCLUSIONS: Both ATY and SUS interpretations in solid pancreatic lesions carry high malignancy risk. Smears show clearer morphologic features for upgrading from ATY to SUS, whereas FNBs demonstrate fewer discriminating features and lower reproducibility. These findings support continued refinement of specimen-type-specific morphologic criteria and ongoing education to reduce variability in reporting.
引用
- Al-Attar MM, Sardana R, Zhao M, et al. Atypical and suspicious diagnoses in solid pancreatic lesions: Cytomorphologic features and interobserver variability in FNA smears and biopsies. Cancer Cytopathol. 2026. PMID: 42145212. doi:10.1002/cncy.70113
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。